Delivery Order SPE2DB22D1017-SPE2DB25FG4AS
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 16, 2025, for CellCept 250 mg capsules (100-count units) with a ceiling value of $17,152.58. This firm fixed-price delivery order, which is due for completion by July 17, 2025, represents a non-set-aside competitive award under the broader pharmaceutical supply framework. The contract will be performed at AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency's Medical Supply Chain for the supply of CellCept 500 mg tablets (500-count bottles). The contract, awarded May 12, 2025, carries a firm fixed price ceiling value of $8,316.17 with an ultimate completion date of May 13, 2025. This delivery order represents a non-set-aside, competitively awarded procurement and is classified as a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively awarded delivery order (Contract No. 4568982464) by the Defense Logistics Agency on August 4, 2025, for the supply of CellCept 500 mg tablets in a quantity of 100 units. This firm fixed-price delivery order carries a ceiling value of $7,817.19 and is scheduled for ultimate completion by August 5, 2025. The contract carries no set-aside designation and will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $27,304.35 by the Defense Logistics Agency on July 10, 2025, for the supply of CellCept 500 mg tablets in quantities of 100. The contract, designated as a child agreement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), carries an ultimate completion date of July 11, 2025. This award was competitively procured with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 2, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $2,987.17. The contract is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025 and was competitively awarded with no set-aside designation. The award is funded by the Medical Supply Chain, a defense-oriented federal agency, with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $1,268.65 firm fixed-price delivery order for 100 tablets of CellCept 500 mg by the Defense Logistics Agency on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed-price contract valued at $17,337.23. This non-set-aside award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $13,249.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). The contract was competitively awarded without set-aside designation and is set for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $12,986.33 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500 count) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price, competitively awarded delivery order represents a single pharmaceutical product shipment with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 29, 2025, for 500 mg mycophenolate tablets (500-count) valued at $1,809.24. This firm fixed-price, non-set-aside delivery order is part of the company's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The contract is funded by...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4ASDelivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for CellCept 200 mg/mL oral suspension (160 mL). This firm fixed-price contract, valued at $1,093.31, represents a non-competitive set-aside delivery order with an ultimate completion date of June 3, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the product will support federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle that runs through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and other critical medical commodities. The Defense Logistics Agency's Medical Supply Chain relies on such contracts to ensure consistent availability of essential pharmaceutical products for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/2/25 |